Back to Search Start Over

A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial

Authors :
Kobayashi, Masatake
Huttin, Olivier
Ferreira, João Pedro
Duarte, Kevin
González, Arantxa
Heymans, Stephane
Verdonschot, Job A.J.
Rocca, Hans‐peter Brunner‐la
Pellicori, Pierpaolo
Clark, Andrew
Petutschnigg, Johannes
Edelmann, Frank
Cleland, John
Rossignol, Patrick
Zannad, Faiez
Girerd, Nicolas
Défaillance Cardiovasculaire Aiguë et Chronique (DCAC)
Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)
Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P)
Centre d'investigation clinique [Nancy] (CIC)
Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)
Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT)
Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy]
French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT )
Faculdade de Medicina da Universidade do Porto (FMUP)
Universidade do Porto = University of Porto
Navarra Institute for Health Research / Instituto de Investigación Sanitaria de Navarra (IdiSNA)
Universidad Pública de Navarra [Espagne] = Public University of Navarra (UPNA)-Universidad de Navarra [Pamplona] (UNAV)-Clínica Universidad de Navarra [Pamplona]
Institute of Health Carlos III
Center for Applied Medical Research [Plamplona] (CIMA)
Universidad de Navarra [Pamplona] (UNAV)
Cardiovascular Research Institute Maastricht (CARIM)
Maastricht University [Maastricht]
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
University of Glasgow
University of Hull [United Kingdom]
Castle Hill Hospital
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
German Center for Cardiovascular Research (DZHK)
Berlin Institute of Health (BIH)
European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013)
Source :
European Journal of Heart Failure, European Journal of Heart Failure, 2023, ⟨10.1002/ejhf.2859⟩
Publication Year :
2023
Publisher :
HAL CCSD, 2023.

Abstract

International audience; Background: An echocardiographic algorithm derived by machine learning (e'VM) characterizes preclinical individuals with different cardiac structure and function, biomarkers, and long-term risk of heart failure (HF). Our aim was the external validation of the e'VM algorithm and to explore whether it may identify subgroups who benefit from spironolactone.Methods: The HOMAGE (Heart OMics in Aging) trial enrolled participants at high risk of developing HF randomly assigned to spironolactone or placebo over 9 months. The e'VM algorithm was applied to 416 participants (mean age 74±7years, 25% women) with available echocardiographic variables (i.e., e' mean, left ventricular [LV] end-diastolic volume and mass indexed by body surface area [LVMi]). The effects of spironolactone on changes in echocardiographic and biomarker variables were assessed across e'VM phenotypes.Results: A majority (>80%) had either "diastolic changes (D)", or "diastolic changes with structural remodeling (D/S)" phenotype. D/S phenotype had the highest LVMi, left atrial volume, E/e', natriuretic peptide and troponin levels (all p0.10; Pinteraction

Details

Language :
English
ISSN :
13889842
Database :
OpenAIRE
Journal :
European Journal of Heart Failure, European Journal of Heart Failure, 2023, ⟨10.1002/ejhf.2859⟩
Accession number :
edsair.od......3379..7907d074f4511aa6e3628b5fb3e880f8